Wolfgang Kress

Wolfgang Kress is an experienced professional in the field of drug product development and analytics, currently serving as Drug Product & Analytics Leader at CDR-Life Inc. since August 2020. Previous roles include Analytical Project Leader and Fellow in Late Phase Analytical Development at Novartis from December 2016 to March 2020, where work focused on late phase analytical development and characterization. Wolfgang also led analytics development at ESBATech AG as Group Leader, managing the development and qualification of analytical methods for product release, impurity characterization, and stability studies from November 2011 to November 2016. Earlier experience includes positions at Cytos Biotechnology AG as Scientist in Downstream Processing and a Postdoctoral Fellowship at ETH Zurich. Wolfgang holds a PhD in Molecular Biology/Biophysics from ETH Zurich and a Diplom in Biochemistry from The Martin Luther University of Halle-Wittenberg.